EssilorLuxottica and Zhejiang Institute for Medical Device Testing Sign Strategic Cooperation Agreement to Accelerate Ophthalmic Instrument Innovation

SHANGHAI, Nov. 8, 2021 /PRNewswire/ -- Today, EssilorLuxottica Group, a global leader in vision care and eyewear manufacturing, signed a strategic cooperation agreement with the Zhejiang Institute for Medical Device Testing to jointly promote the establishment of a testing research and evaluation system for optometric measuring instruments, thereby accelerating the R&D and market launch of innovative measuring devices in the optometry field to benefit more patients with vision impairment in China and worldwide.

Strategic Cooperation Signing Ceremony between EssilorLuxottica Group and Zhejiang Institute of Medical Device Testing

For years, the EssilorLuxottica Group has been committed to delivering advanced optometric screening, precise vision correction, and eye health protection solutions to consumers in China. As a key component of this strategic partnership, both parties will initially collaborate on the testing and validation technology for the "liquid lens" fully automated intelligent refraction system developed by the EssilorLuxottica Group, thereby accelerating the commercial launch of this innovative optometric product.

“As a world-first innovation, the “liquid lens” technology simultaneously displays the sphere, cylinder, and axis measurements obtained during refraction in 1-diopter increments directly to the patient, significantly enhancing the refraction experience; meanwhile, intelligent algorithms powered by big data ensure greater accuracy in refractive testing, while streamlining the workflow for improved efficiency and reduced reliance on personnel. This makes professional optometry accessible to a broader population and provides highly precise refractive tracking for myopia prevention and control in children and adolescents. Additionally, the short-distance version of the liquid lens automated refractometer enables professional, accurate, and rapid refractive measurements in any setting.”

The Zhejiang Institute for Medical Device Testing is one of the ten national-level medical device testing centers under the National Medical Products Administration. It is a national-level testing institution specializing in the quality supervision and inspection of medical devices and certification testing of medical device products, primarily engaged in national standardization work in the field of medical optics and instruments. Its medical optics and laser testing laboratories are at the leading level in China. Particularly in the field of ophthalmic and optometric equipment, it serves as an authoritative technical research and testing institution in China.

“We highly look forward to this collaboration with the Zhejiang Institute for Medical Device Testing. We hope that this partnership will accelerate the pre-market testing procedures for this product. While advancing the product's market launch, we aim to enhance the testing and evaluation system for innovative products in the vision care industry, and simultaneously bring more innovative instruments to China's vision care sector and consumers,” said Chen Luyi, Vice President of Greater China, Instruments Division at Essilor, at the signing ceremony.

Chen Luyi, Vice President, Greater China, Instrument Division, Essilor

Shen Lixin, Director of the Zhejiang Institute of Medical Device Testing, stated: “China has the largest myopic population in the world, and vision health issues, including myopia, are particularly prominent. We highly anticipate that the introduction of innovative testing instruments and solutions for vision problems will help improve this situation. At the same time, we will actively develop corresponding testing methods and evaluation systems for such innovative devices. We are greatly pleased to have reached a strategic cooperation agreement with EssilorLuxottica on the platform of the China International Import Expo (CIIE). By leveraging our respective strengths, we will drive the innovation of evaluation systems and testing methods, and expedite the introduction of advanced foreign technologies into the Chinese market.”

Shen Lixin, Director of the Zhejiang Provincial Medical Device Testing and Research Institute

Du Manuo, President of EssilorLuxottica Greater China, expressed high expectations for the partnership: “Today, we are delighted to welcome a new partner -- the Zhejiang Institute for Medical Device Testing. This is another initiative underscoring our commitment to taking root in the Chinese market, facilitating the implementation of innovative technologies, and driving the high-quality development of the industry. We also look forward to collaborating with more industry partners in the future to accelerate innovation and deliver more comprehensive and standardized optometry and vision care services and experiences to consumers across China and the world.”

EssilorLuxottica Signs Strategic Cooperation Agreement with Zhejiang Institute for Medical Device Testing